Literature DB >> 8105473

Functional expression of mouse mdr1 in Escherichia coli.

E Bibi1, P Gros, H R Kaback.   

Abstract

We describe functional expression of the mouse multidrug-resistance protein (P-glycoprotein; P-gp) in an Escherichia coli mutant defective in the outer membrane protease ompT. Heterologously expressed mdr1 appears as an unglycosylated species with an apparent molecular mass of 140 kDa in the membrane of the mutant. Unglycosylated mdr1 retains the ability to bind the photoactivatable drug analog [125I]iodoarylazidoprazosin and confers resistance to tetraphenylphosphonium (TPP+) and tetraphenylarsonium (TPA+), known mdr1 substrates. In vivo resistance is linked to reduced cellular accumulation and energy-dependent efflux of the lipophilic cations. Surprisingly, discrete mutations in the predicted nucleotide binding folds of mdr1 that abolish drug resistance in mammalian cells have no apparent effect on TPA+ efflux via mdr1 in E. coli.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105473      PMCID: PMC47532          DOI: 10.1073/pnas.90.19.9209

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Membrane potential and active transport in membrane vesicles from Escherichia coli.

Authors:  S Schuldiner; H R Kaback
Journal:  Biochemistry       Date:  1975-12-16       Impact factor: 3.162

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins.

Authors:  P Gros; J Croop; D Housman
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

4.  A complementation analysis of the restriction and modification of DNA in Escherichia coli.

Authors:  H W Boyer; D Roulland-Dussoix
Journal:  J Mol Biol       Date:  1969-05-14       Impact factor: 5.469

5.  Functional and immunochemical characterization of a mutant of Escherichia coli energy uncoupled for lactose transport.

Authors:  D Herzlinger; N Carrasco; H R Kaback
Journal:  Biochemistry       Date:  1985-01-01       Impact factor: 3.162

6.  Site-directed mutagenesis of cys148 in the lac carrier protein of Escherichia coli.

Authors:  W R Trumble; P V Viitanen; H K Sarkar; M S Poonian; H R Kaback
Journal:  Biochem Biophys Res Commun       Date:  1984-03-30       Impact factor: 3.575

7.  Lactose carrier protein of Escherichia coli. Structure and expression of plasmids carrying the Y gene of the lac operon.

Authors:  R M Teather; J Bramhall; I Riede; J K Wright; M Fürst; G Aichele; U Wilhelm; P Overath
Journal:  Eur J Biochem       Date:  1980

8.  Vinblastine photoaffinity labeling of a high molecular weight surface membrane glycoprotein specific for multidrug-resistant cells.

Authors:  A R Safa; C J Glover; M B Meyers; J L Biedler; R L Felsted
Journal:  J Biol Chem       Date:  1986-05-15       Impact factor: 5.157

9.  Membrane vesicles from multidrug-resistant human cancer cells contain a specific 150- to 170-kDa protein detected by photoaffinity labeling.

Authors:  M M Cornwell; A R Safa; R L Felsted; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

10.  Quantitative measurements of membrane potential in Escherichia coli.

Authors:  H Felle; J S Porter; C L Slayman; H R Kaback
Journal:  Biochemistry       Date:  1980-07-22       Impact factor: 3.162

View more
  19 in total

1.  Membrane topology of the multidrug transporter MdfA: complementary gene fusion studies reveal a nonessential C-terminal domain.

Authors:  Julia Adler; Eitan Bibi
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

2.  Functional expression of mouse Mdr1 in an outer membrane permeability mutant of Escherichia coli.

Authors:  O Béjà; E Bibi
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  The secondary multidrug/proton antiporter MdfA tolerates displacements of an essential negatively charged side chain.

Authors:  Nadejda Sigal; Nir Fluman; Shira Siemion; Eitan Bibi
Journal:  J Biol Chem       Date:  2009-01-07       Impact factor: 5.157

Review 4.  The sodium/multivitamin transporter: a multipotent system with therapeutic implications.

Authors:  Matthias Quick; Lei Shi
Journal:  Vitam Horm       Date:  2015-03-07       Impact factor: 3.421

5.  Manipulating the drug/proton antiport stoichiometry of the secondary multidrug transporter MdfA.

Authors:  Osnat Tirosh; Nadejda Sigal; Amir Gelman; Nadav Sahar; Nir Fluman; Shira Siemion; Eitan Bibi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-16       Impact factor: 11.205

Review 6.  Biogenesis of CFTR and other polytopic membrane proteins: new roles for the ribosome-translocon complex.

Authors:  H Sadlish; W R Skach
Journal:  J Membr Biol       Date:  2004-12       Impact factor: 1.843

7.  Determination of transmembrane topology of an inward-rectifying potassium channel from Arabidopsis thaliana based on functional expression in Escherichia coli.

Authors:  N Uozumi; T Nakamura; J I Schroeder; S Muto
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

8.  Employing Escherichia coli to functionally express, purify, and characterize a human transporter.

Authors:  Matthias Quick; Ernest M Wright
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-19       Impact factor: 11.205

9.  Functional expression of P-glycoprotein in Saccharomyces cerevisiae confers cellular resistance to the immunosuppressive and antifungal agent FK520.

Authors:  M Raymond; S Ruetz; D Y Thomas; P Gros
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

10.  Characterization of membrane potential-dependent uptake of the novel PET tracer 18F-fluorobenzyl triphenylphosphonium cation.

Authors:  Igal Madar; Hayden Ravert; Barry Nelkin; Masroor Abro; Martin Pomper; Robert Dannals; James J Frost
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-05       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.